Beschreibung
Immunological parameters including regulatory T-cell populations and immunoglobulin levels are assessed in curcumin-treated ulcerative colitis patients. Shifts toward anti-inflammatory immune profiles are suggested.
Figure 26
ChartSource Paper
The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.Cite This Figure
![Figure 26: Immunological parameters including regulatory T-cell populations and immunoglobulin levels are assessed in curcumin-treated ulcerative colitis patients. Shifts toward anti-inflammatory immune profiles are suggested.]() > Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)
<figure> <img src="" alt="Immunological parameters including regulatory T-cell populations and immunoglobulin levels are assessed in curcumin-treated ulcerative colitis patients. Shifts toward anti-inflammatory immune profiles are suggested." /> <figcaption>Figure 26. Immunological parameters including regulatory T-cell populations and immunoglobulin levels are assessed in curcumin-treated ulcerative colitis patients. Shifts toward anti-inflammatory immune profiles are suggested.<br> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption> </figure>